To: Jack Rayfield who wrote (4084 ) 7/3/1999 12:15:00 PM From: HotShot1 Read Replies (1) | Respond to of 8117
Jack, I think the only way this stock will appreciate to $2.20 by next year is if significant pre-orders/current orders are revealed. What concerns me is not RM's extension of their trials to the end of the year. In fact, I am certain that they will become a regular customer eventually. However, where are the orders from the sites that have completed their trials? Are they not pre-ordering this thing, or are the orders so tiny that the company feels an announcement would have a negative impact? And what happened to the military? They finished their trials months ago, and not a single pre-order has been announced? Is it viable at $98.50? I don't think liquidity will be to big a concern over the next 12-18 months, even if the options are not exercised (I don't think they will be). The reason is that production will be on a small scale through 1999-2000, so expenses will remain minimal. Currently, I don't think there is much spending going on. The company's overhead must be very little right now, as I can't see what major expenses they are incurring. So I think the company is safe right now financially, but I'm beginning to wonder how much money this company will ever make. Is it going to be a nickel and dime business, a few units here a few units there? I mean, RM has only been using 5 a month, and they will probably be the company's biggest customer! If the whole RM system eventually adopts it, then good revenue will be posted. But how long will that take? Based on state requirements for approval, abbreviated trials etc, it could take years. I don't have that much time to wait.